196 related articles for article (PubMed ID: 28749588)
21. The new World Health Organization-European Organization for Research and Treatment of Cancer classification for cutaneous lymphomas: a practical marriage of two giants.
Slater DN
Br J Dermatol; 2005 Nov; 153(5):874-80. PubMed ID: 16225594
[TBL] [Abstract][Full Text] [Related]
22. Primary cutaneous CD8(+) small- to medium-sized lymphoproliferative disorder in extrafacial sites: clinicopathologic features and concept on their classification.
Kempf W; Kazakov DV; Cozzio A; Kamarashev J; Kerl K; Plaza T; Metze D
Am J Dermatopathol; 2013 Apr; 35(2):159-66. PubMed ID: 22885550
[TBL] [Abstract][Full Text] [Related]
23. Primary Cutaneous CD4+ Small/Medium T-Cell Lymphoproliferative Disorder or Primary Cutaneous Marginal Zone B-Cell Lymphoma? Two Distinct Entities With Overlapping Histopathological Features.
Bakr F; Wain EM; Barlow R; Robson A
Am J Dermatopathol; 2021 Dec; 43(12):e204-e212. PubMed ID: 34231494
[TBL] [Abstract][Full Text] [Related]
24. Primary cutaneous CD4+ small- to medium-sized pleomorphic T-cell lymphoproliferative disorder in a pediatric patient successfully treated with low-dose radiation.
Kim EJ; Aria AB; Wilmas K; Lewis DJ; Torres-Cabala CA; Nunez C; Dabaja BS; Duvic M
Pediatr Dermatol; 2019 Jan; 36(1):e23-e26. PubMed ID: 30548331
[TBL] [Abstract][Full Text] [Related]
25. Ultrasound Appearance of Primary Cutaneous CD4+ Small/Medium-Sized T-Cell Lymphoproliferative Disorder.
Rodríguez-Lomba E; Molina-López I; Pulido-Pérez A; Ciudad-Blanco C
Actas Dermosifiliogr; 2017 Oct; 108(8):792-794. PubMed ID: 28388988
[No Abstract] [Full Text] [Related]
26. Adnexotropism as a Histopathological Clue for the Diagnosis of Primary Cutaneous CD4+ Small/Medium-Sized T-Cell Lymphoproliferative Disorder.
Pérez González YC; Llamas Velasco MDM; Díaz Recuero JL; Machan S; Núñez Hipolito L; Piris Pinilla MA; Rodríguez Pinilla SM
Am J Dermatopathol; 2020 May; 42(5):383-384. PubMed ID: 31313694
[No Abstract] [Full Text] [Related]
27. Cutaneous Richter Syndrome Mimicking Primary Cutaneous CD4-Positive Small/Medium T-cell Lymphoma: Case Report and Review of the Literature.
Rito M; Cabeçadas J; Costa Rosa J; Cravo M; Robson A
Am J Dermatopathol; 2018 Apr; 40(4):286-290. PubMed ID: 28937430
[TBL] [Abstract][Full Text] [Related]
28. Primary cutaneous CD4+ small/medium T-cell lymphoproliferative disorder: a case with multiple tumors.
Sarac E; Demirkesen C
An Bras Dermatol; 2023; 98(5):720-722. PubMed ID: 37225627
[No Abstract] [Full Text] [Related]
29. Primary cutaneous CD4+ small- to medium-sized pleomorphic T-cell lymphoma: temporary remission by oral doxycycline.
Toberer F; Hartschuh W; Hadaschik E
JAMA Dermatol; 2013 Aug; 149(8):956-9. PubMed ID: 23760549
[TBL] [Abstract][Full Text] [Related]
30. Primary cutaneous CD4+ small-/medium-sized pleomorphic T-cell lymphoma: a cutaneous nodular proliferation of pleomorphic T lymphocytes of undetermined significance? A study of 136 cases.
Beltraminelli H; Leinweber B; Kerl H; Cerroni L
Am J Dermatopathol; 2009 Jun; 31(4):317-22. PubMed ID: 19461234
[TBL] [Abstract][Full Text] [Related]
31. Primary Cutaneous CD4 Small/Medium T-Cell Lymphoproliferative Disorder Following COVID-19 Vaccination-What Do We Know about Lymphoproliferative Disorders and Cutaneous Lymphomas after COVID-19 Vaccination? A Report of an Atypical Case and a Review of the Literature.
De la Torre-Gomar FJ; Llamas-Molina JM; Pegalajar-García MD; Pérez-Valencia C; Carrero-Castaño A; Ruiz-Villaverde R
Life (Basel); 2024 Mar; 14(3):. PubMed ID: 38541710
[TBL] [Abstract][Full Text] [Related]
32. Therapeutic hotline: Primary cutaneous CD4 + small/medium-sized pleomorphic T cell lymphoma coexisting with myelodysplastic syndrome transforming into chronic myelomonocytic leukemia successfully treated with cyclophosphamide.
Wawrzycki B; Chodorowska G; Pietrzak A; Jazienicka I; Skomra D; Kowal M; Dybiec E; Hercogova J
Dermatol Ther; 2010; 23(6):676-81. PubMed ID: 21054711
[TBL] [Abstract][Full Text] [Related]
33. The applicability of the new WHO-EORTC classification of primary cutaneous lymphomas to a single referral center.
Khamaysi Z; Ben-Arieh Y; Izhak OB; Epelbaum R; Dann EJ; Bergman R
Am J Dermatopathol; 2008 Feb; 30(1):37-44. PubMed ID: 18212543
[TBL] [Abstract][Full Text] [Related]
34. Case for diagnosis. Primary cutaneous CD4+ small/medium T-cell lymphoproliferative disorder.
Valentim FO; Oliveira CC; Miot HA
An Bras Dermatol; 2019; 94(1):99-101. PubMed ID: 30726474
[TBL] [Abstract][Full Text] [Related]
35. Primary cutaneous lymphoproliferative disorders with dual lineage rearrangement.
Kazakov DV; Kutzner H; Palmedo G; Boudova L; Michaelis S; Michal M; Vanecek T; Magro CM; Mukensnabl P; Dummer R; Burg G; Kempf W
Am J Dermatopathol; 2006 Oct; 28(5):399-409. PubMed ID: 17012914
[TBL] [Abstract][Full Text] [Related]
36. Non-mycosis fungoides cutaneous T-cell lymphoma: reclassification according to the WHO-EORTC classification.
Weaver J; Mahindra AK; Pohlman B; Jin T; Hsi ED
J Cutan Pathol; 2010 May; 37(5):516-24. PubMed ID: 20132421
[TBL] [Abstract][Full Text] [Related]
37. Indolent T- and NK-cell lymphoproliferative disorders of the gastrointestinal tract: a review and update.
Matnani R; Ganapathi KA; Lewis SK; Green PH; Alobeid B; Bhagat G
Hematol Oncol; 2017 Mar; 35(1):3-16. PubMed ID: 27353398
[TBL] [Abstract][Full Text] [Related]
38. Long-term follow-up and management of small and medium-sized CD4
Virmani P; Jawed S; Myskowski PL; Horwitz S; Skripnik Lucas A; Moskowitz A; Pulitzer M; Zain J; Rosen ST; Querfeld C
Int J Dermatol; 2016 Nov; 55(11):1248-1254. PubMed ID: 27369070
[TBL] [Abstract][Full Text] [Related]
39. Coincident Primary Cutaneous CD4+ Small/Medium-Sized Pleomorphic T-Cell Lymphoproliferative Disorder in Two Sisters.
Ponce S; Peñate Y; Montenegro T
Actas Dermosifiliogr (Engl Ed); 2020 Apr; 111(3):271-273. PubMed ID: 31980130
[No Abstract] [Full Text] [Related]
40. Surgical, Dermatological and Morphopathological Considerations in the Diagnosis and Treatment of Cutaneous Lymphoproliferative Tumors, Primary CD4.
Ardeleanu V; Moroianu LA; Sava A; Tebeica T; Jecan RC; Moroianu M; Tatu AL
Medicina (Kaunas); 2022 Nov; 58(11):. PubMed ID: 36363575
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
